Pharmacist check prevents cancer drug Mix-Ups

NCT ID NCT04142567

First seen Mar 08, 2026 · Last updated Jun 09, 2026 · Updated 22 times

Summary

This study tested whether having a clinical pharmacist review medications before cancer treatment starts can prevent drug-related problems, especially dangerous drug interactions. Researchers observed 440 adults with solid tumors who were about to begin chemotherapy, immunotherapy, or oral targeted therapy. The pharmacist identified and helped fix issues like harmful drug combinations, potentially improving safety without changing the cancer treatment itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • APHP -Cochin Hospital and Georges Pompidou European Hospital

    Paris, 75014, France

Conditions

Explore the condition pages connected to this study.